154 related articles for article (PubMed ID: 33021155)
21. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
22. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
Brody JR; Costantino CL; Berger AC; Sato T; Lisanti MP; Yeo CJ; Emmons RV; Witkiewicz AK
Cell Cycle; 2009 Jun; 8(12):1930-4. PubMed ID: 19448397
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood.
Ikemoto T; Shimada M; Komatsu M; Yamada S; Saito Y; Mori H; Morine Y; Imura S; Bando Y; Utsunomiya T
Pancreas; 2013 Jan; 42(1):130-4. PubMed ID: 22722263
[TBL] [Abstract][Full Text] [Related]
24. Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection.
Boasso A; Vaccari M; Hryniewicz A; Fuchs D; Nacsa J; Cecchinato V; Andersson J; Franchini G; Shearer GM; Chougnet C
J Virol; 2007 Nov; 81(21):11593-603. PubMed ID: 17715231
[TBL] [Abstract][Full Text] [Related]
25. Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
Chevolet I; Schreuer M; Speeckaert R; Neyns B; Hoorens I; van Geel N; Krüse V; Hennart B; Allorge D; Van Gele M; Brochez L
Melanoma Res; 2015 Aug; 25(4):357-61. PubMed ID: 26050145
[TBL] [Abstract][Full Text] [Related]
26. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
Front Immunol; 2020; 11():120. PubMed ID: 32117271
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
[TBL] [Abstract][Full Text] [Related]
28. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells.
Liu X; Liu Y; Ding M; Wang X
Mol Med Rep; 2011; 4(1):53-8. PubMed ID: 21461563
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
[TBL] [Abstract][Full Text] [Related]
31. Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.
Sharma R; Di Dalmazi G; Caturegli P
Thyroid; 2016 Aug; 26(8):1117-24. PubMed ID: 27296629
[TBL] [Abstract][Full Text] [Related]
32. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.
Niinisalo P; Oksala N; Levula M; Pelto-Huikko M; Järvinen O; Salenius JP; Kytömäki L; Soini JT; Kähönen M; Laaksonen R; Hurme M; Lehtimäki T
Ann Med; 2010; 42(1):55-63. PubMed ID: 19941414
[TBL] [Abstract][Full Text] [Related]
33. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
34. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma.
Tominaga M; Horiuchi Y; Ichikawa M; Yamashita M; Okano K; Jikumaru Y; Nariai Y; Kadosawa T
J Vet Diagn Invest; 2010 May; 22(3):438-41. PubMed ID: 20453222
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Front Immunol; 2018; 9():950. PubMed ID: 29867939
[TBL] [Abstract][Full Text] [Related]
37. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
38. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
39. Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.
Asghar K; Loya A; Rana IA; Abu Bakar M; Farooq A; Tahseen M; Ishaq M; Rashid MU
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3521-3525. PubMed ID: 31759380
[TBL] [Abstract][Full Text] [Related]
40. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
Witkiewicz A; Williams TK; Cozzitorto J; Durkan B; Showalter SL; Yeo CJ; Brody JR
J Am Coll Surg; 2008 May; 206(5):849-54; discussion 854-6. PubMed ID: 18471709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
